Citation record · dewpoint-2025-dewpoint-therapeutics-closes

Dewpoint Therapeutics, Dewpoint Therapeutics closes Series D financing to advance first-in-class condensate modulator (c-mod) into clinical development for gastric cancer — company press release via GlobeNewswire (2025) (sponsor’s own figures)

program 2025 not re-checked

Authors. Dewpoint Therapeutics

Venue. — company press release via GlobeNewswire (sponsor’s own figures)

How the Institute flags it

speculative 1 time

The evidence base